LTFS
KBIO

Ladenburg Thalmann Financial Services’s KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) KBIO Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio KBIO Stock Details KBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-29
Closed – – 4954
2015
Q1 		$0 Hold
29
– – ﹤0.01% 4856
2014
Q4 		$0 Hold
29
– – ﹤0.01% 4630
2014
Q3 		$0 Hold
29
– – ﹤0.01% 4229
2014
Q2 		$1K Buy
+29
New +$496 ﹤0.01% 3872

Other funds holding KBIO

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
OWIM
Old West Investment Management Los Angeles, California $923M AUM 112.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Ladenburg Thalmann Financial Services's KBIO Position: Q2 2015 in Review

Ladenburg Thalmann Financial Services sold out of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) in Q2 2015, closing a stake of 29 shares.

Ladenburg Thalmann Financial Services first reported a position in KBIO in Q2 2014 and held it in 4 quarters. The position peaked at $1K in Q2 2014. 19 funds tracked by Wall St. Rank hold KBIO as of Q2 2015.

  • Ladenburg Thalmann Financial Services reported no remaining KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position as of Q2 2015 after selling out during the quarter.
  • Ladenburg Thalmann Financial Services sold 29 KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) shares in Q2 2015.
  • Ladenburg Thalmann Financial Services first reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in Q2 2014 and held it in 4 quarters.
  • Ladenburg Thalmann Financial Services's KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position peaked at $1K in Q2 2014.
  • 19 funds tracked by Wall St. Rank held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) as of Q2 2015.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q2 2015, filed 14 Aug 2015.